- $458.33m
- $1.12bn
- $148.21m
- 41
- 62
- 56
- 54
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 120.68 | ||
| PEG Ratio (f) | 1.63 | ||
| EPS Growth (f) | 287.36% | ||
| Dividend Yield (f) | 9.25% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.95 | ||
| Price to Tang. Book | 0.96 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3.27 | ||
| EV to EBITDA | 13.92 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -0.66% | ||
| Return on Equity | -2.32% | ||
| Operating Margin | -5.55% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 115.94 | 137.28 | 141.05 | 138.78 | 148.21 | 151.54 | 157.29 | 9.6% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | -41.08 | -97.95 | +1043.4 | -68.31 | +626.3 | +40.35 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Global Medical REIT Inc. is an internally managed real estate investment trust (REIT). The Company acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. The Company conducts its business through a wholly owned subsidiary of its operating partnership, Global Medical REIT L.P. It owns 92.6% of the outstanding common operating partnership units (OP Units) of its operating partnership, with an aggregate of 7.4% of the Operating Partnership owned by holders of long-term incentive plan units (LTIP Units) and third-party limited partners who contributed properties or services to the operating partnership in exchange for OP Units. Its portfolio includes medical office buildings (MOBs), inpatient rehab. facility (IRF), surgical hospitals and others. The Company's portfolio is located in various areas, including Texas, Florida, Ohio, Pennsylvania, Illinois, Arizona, and Michigan.
Directors
- Jeffrey Busch CHM (64)
- Robert Kiernan CFO (55)
- Danica Holley COO (48)
- Alfonzo Leon CIN (45)
- Jamie Barber GCN (44)
- Henry Cole LED (76)
- Huiqi Zhang DRC (31)
- Paula Crowley IND (66)
- Matthew Cypher IND (44)
- Ronald Marston IND (78)
- Roscoe Moore IND (76)
- Lori Wittman IND (62)
- Last Annual
- December 31st, 2025
- Last Interim
- December 31st, 2025
- Incorporated
- January 6th, 2014
- Public Since
- November 2nd, 2012
- No. of Employees
- 26
- Sector
- Residential & Commercial REITs
- Industry
- Financials
- Exchange
New York Stock Exchange
- Shares in Issue
- 13,235,000

- Address
- 7373 Wisconsin Avenue, Suite 800, BETHESDA, 20814
- Web
- https://www.chironre.com
- Phone
- +1 2025246851
- Contact
- Evelyn Infurna
- Auditors
- Deloitte & Touche LLP
Upcoming Events for XRN
Dividend For XRN_pb.N - 0.5000 USD
Dividend For XRN_pa.N - 0.4688 USD
Dividend For XRN.N - 0.2500 USD
Chiron Real Estate Inc Annual Shareholders Meeting
Q1 2026 Chiron Real Estate Inc Earnings Release
Dividend For XRN.N - 0.2500 USD
Q2 2026 Chiron Real Estate Inc Earnings Release
Similar to XRN
Acadia Realty Trust
New York Stock Exchange
Acres Commercial Realty
New York Stock Exchange
Agree Realty
New York Stock Exchange
Alexander & Baldwin (Hawaii)
New York Stock Exchange
Alexanders
New York Stock Exchange
FAQ
As of Today at 18:56 UTC, shares in Chiron Real Estate are trading at $36.60. This share price information is delayed by 15 minutes.
Shares in Chiron Real Estate last closed at $36.60 and the price had moved by -13.78% over the past 365 days. In terms of relative price strength the Chiron Real Estate share price has underperformed the S&P500 Index by -26.85% over the past year.
The overall consensus recommendation for Chiron Real Estate is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Chiron Real Estate dividend yield is 11.55% based on the trailing twelve month period.
Last year, Chiron Real Estate paid a total dividend of $4.23, and it currently has a trailing dividend yield of 11.55%.Looking ahead, shares in Chiron Real Estate are due to go ex-dividend on 2026-03-20 and the next dividend pay date is 2026-04-17.
Chiron Real Estate are due to go ex-dividend on 2026-03-20 and the next dividend pay date is 2026-04-17. The historic dividend yield on Chiron Real Estate shares is currently 11.55%.
To buy shares in Chiron Real Estate you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $36.60, shares in Chiron Real Estate had a market capitalisation of $458.33m.
Here are the trading details for Chiron Real Estate:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: XRN
Based on an overall assessment of its quality, value and momentum Chiron Real Estate is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Chiron Real Estate is $44.24. That is 20.88% above the last closing price of $36.60.
Analysts covering Chiron Real Estate currently have a consensus Earnings Per Share (EPS) forecast of $0.29 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Chiron Real Estate. Over the past six months, its share price has underperformed the S&P500 Index by -9.37%.
As of the last closing price of $36.60, shares in Chiron Real Estate were trading +7.44% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Chiron Real Estate PE ratio based on its reported earnings over the past 12 months is 120.68. The shares last closed at $36.60.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Chiron Real Estate's management team is headed by:
- Jeffrey Busch - CHM
- Robert Kiernan - CFO
- Danica Holley - COO
- Alfonzo Leon - CIN
- Jamie Barber - GCN
- Henry Cole - LED
- Huiqi Zhang - DRC
- Paula Crowley - IND
- Matthew Cypher - IND
- Ronald Marston - IND
- Roscoe Moore - IND
- Lori Wittman - IND





